Biomind Labs Inc.
BMNDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $23,428 | $7,476 | $27,363 | $77,104 |
| - Cash | $0 | $24 | $26 | $2,274 |
| + Debt | $671 | $736 | $8 | $45 |
| Enterprise Value | $24,098 | $8,188 | $27,345 | $74,876 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$8 | -$15 | -$42 | -$28 |
| % Margin | – | – | – | – |
| EBITDA | -$396 | -$1,035 | -$2,891 | -$3,399 |
| % Margin | – | – | – | – |
| Net Income | -$260 | -$1,214 | -$2,986 | -$4,332 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.003 | -0.016 | -0.04 | -0.06 |
| % Growth | 79% | 59.4% | 33.5% | – |
| Operating Cash Flow | -$354 | -$766 | -$2,151 | -$2,123 |
| Capital Expenditures | $0 | $0 | $0 | -$45 |
| Free Cash Flow | -$354 | -$766 | -$2,151 | -$2,167 |